Compound Profile: PHARMADRO P 100 Pharmacom
PHARMADRO P 100 Pharmacom is a pharmaceutical-grade drostanolone propionate formulation developed for in-vitro research applications. Drostanolone propionate is a synthetic androgenic anabolic steroid derived from dihydrotestosterone, characterised by its unique 2α-methyl modification that prevents aromatisation to estrogen. Researchers investigating androgenic steroid mechanisms frequently examine this compound for its distinctive binding profile to androgen receptors and its resistance to 5α-reductase enzyme conversion. This formulation from Stroid UK Shop provides consistent purity levels for reproducible experimental protocols across multiple research disciplines.
Laboratory Applications
Research scientists examine PHARMADRO P 100 in various experimental contexts, particularly in studies investigating androgenic receptor selectivity and steroid metabolism pathways. The compound’s unique molecular structure makes it valuable for researchers studying the relationship between steroid modification and biological activity in controlled laboratory environments. Investigators frequently analyse this formulation alongside other compounds available in our drostanolone research collection to compare receptor binding affinities and metabolic profiles. Its propionate ester provides researchers with specific pharmacokinetic properties for temporal studies, while the compound’s anti-estrogenic characteristics offer unique research opportunities for scientists investigating hormone modulation mechanisms. Comparative studies often examine this compound against other research chemicals like those found in our SARM collection to evaluate different androgenic modulation approaches.
Research Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Drostanolone Propionate |
| Concentration | 100mg/mL |
| CAS Number | 521-12-0 |
| Molecular Formula | C₂₃H₃₆O₃ |
| Molecular Weight | 360.53 g/mol |
| Storage Requirements | Room temperature, protected from light |
| Manufacturer | Pharmacom Labs |
| Research Grade | Laboratory standard |
Research facilities studying hormone receptor interactions often utilise this formulation alongside other investigational compounds including those available in our peptide research range for comprehensive endocrine system studies.
Compliance Statement
PHARMADRO P 100 Pharmacom is intended exclusively for in-vitro research and laboratory analysis purposes. This product is not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols and safety measures when handling this compound. All experimental work should be conducted by qualified personnel in appropriately equipped research facilities with proper ventilation and safety equipment.
